Think you know the markets? See if you can guess this stock by the chart and clues below. Answer is at the bottom.
- This biotech with a $121 billion market cap reported Q3 earnings Thursday of EPS $3.02 vs $2.79 Est, Rev $5.8B vs $5.73B Est
- Third Point's Dan Loeb liquidated his stake in this company in July 2016.
- Sympathy plays include Johnson & Johnson JNJ and Celgene Corporation CELG
Amgen, Inc. AMGN
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: General
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in